Navigation Links
Medbox, Inc. Comments on California Supreme Court Decision
Date:1/22/2013

HOLLYWOOD, Calif., Jan. 22, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), commented on the recent California Supreme Court decision that denied a review of a landmark medical marijuana case, which has drawn widespread attention from prosecutors and policymakers across the state.

The case stems from a 2010 prosecution of the owner of a medical marijuana dispensary in San Diego. The conviction was overturned by the Fourth District Court of Appeal, and last week the California Supreme Court decided to not review the case – effectively ending any further attempts at prosecution.

Notably, the State Supreme Court took the additional action of refusing to depublish the lower courts findings, thereby affirming the legality of medical marijuana sales in California.

"This is a clear declaration that medical marijuana is here to stay in California," according to Dr. Bruce Bedrick , CEO of Medbox, Inc. "The court has ruled that safe access to medical marijuana is a patient's right, and we support that decision. To date, while we have many machine placements in the state of California, we have taken a conservative approach to expanding our market reach due to conflicting regulations and legal opinions in the state. This recent development will give us the confidence we need to move forward in helping clients setup new clinics without the fear of criminal prosecution."

In related news, the City of San Diego effectively declared an end to their war on medical marijuana with a letter from Mayor Bob Filner ordering civil prosecutors to stop the crackdown on dispensaries.

In the letter sent to the police chief, city attorney and the city's Neighborhood C
'/>"/>

SOURCE Medbox, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Medbox, Inc. Unveils Customer Financing Program
2. Medbox, Inc. Finalizes Manufacturing Plans for 2013 Product Line
3. Medbox, Inc. Announced Increased Funding for Corporate Giving Program in 2013
4. Medbox, Inc. Commences Pursuit of Strategic Acquisitions
5. Medbox, Inc. Offers Guidance and Consultation To Washington State
6. Medbox, Inc. Protects Its Image as a Leader in Sensible Medication Dispensing
7. Medbox, Inc. at the Forefront of Providing Secure Medicine Dispensing Systems to Prisons
8. Medbox, Inc. To Support Referendum Overturning LA City Council Ban on Medical Marijuana Outlets
9. Medbox, Inc. Weighs-in on FDA Evaluation of Prescription Medicine Dispensing Systems
10. Medbox, Inc. Rides a Wave of Local Media Support in Connecticut
11. Novation Submits Comments to FDA in support of Unique Device Identification Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... and Research (A*STAR) and Switzerland,s Cytos ... been dosed in a Phase 1 clinical trial with their ... virus-like particle (VLP) technology. In this first Phase 1 clinical ... and its potential to protect against H1N1 influenza infection will ...
(Date:5/16/2013)... 16, 2013  Today, the National Patient Advocate Foundation ... House of Representatives recently approved a bill that would ... patients higher out-of-pocket fees for newer, more expensive oral ... have more severe side-effects. However, the bill was amended ... will continue to be a barrier to patients with ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
(Date:5/19/2013)... 2013 People in Minnesota have a great ... is offering its 28 Day Fat Loss Formula. The ... comfort of their own home. The product sells for $135 ... can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season ... houses now, but after using the 28 Day Fat Loss ...
(Date:5/19/2013)... May 19, 2013 The muscles in ... their functionality and one of the biggest and most ... nervous system. The peripheral system comprises of peripheral nerves ... cord. These nerves ensure that the limbs and hands, ... when these nerves get damaged due to trauma or ...
(Date:5/19/2013)... According to a new market research report ... 2018): By Applications (Healthcare (Endoscopy, Radiology, Ophthalmology), Surveillance, ... IS, Infrared, X-Ray) And Geography" published by MarketsandMarkets, ... billion in 2012 and is expected to reach ... of 3.84% from 2013 to 2018. In terms ...
(Date:5/19/2013)... May 19, 2013 The report “Feed ... Trends & Forecasts up to 2017” published by MarketsandMarkets, ... with analysis and forecasting of the global volume and ... the driving and restraining factors for the global market ... and challenges. The market is segmented and revenue is ...
(Date:5/19/2013)... Americans live closer to their dogs than ever ... Association (AVMA) U.S. Pet Ownership and Demographics Sourcebook, more ... a member of the family, up from the 53.5% ... earlier. , According to the American Pet Products Association, ... to pets has increased every year without interruption, including ...
Breaking Medicine News(10 mins):Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3
... A consortium of federal agencies and nongovernmental organizations has ... and data-collection methods for use in asthma clinical research. ... Outcomes Workshop, which appears as a supplement to the ... and Clinical Immunology , resulted from a meeting organized ...
... FRIDAY, March 2 (HealthDay News) -- Women become less likely ... first year of college, new research finds. Declining condom ... had worse grades and who came from poorer backgrounds. ... unplanned pregnancies and sexually transmitted diseases, yet there has been ...
... people who consume drugs containing cannabinoid compounds found in ... Marsicano (Inserm Research Unit 862) in collaboration with a ... mechanism by which these substances affect working memory. These ... adverse effect of cannabinoids on working memory is exerted ...
... in childhood have a higher risk of infertility in ... Balcerek and her co-authors in a study published in ... 109[7] 126-31). , In a nationwide German survey on ... the authors collected data from former pediatric oncology patients. ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, March ... to screen for cervical cancer are more likely to survive ... Swedish study suggests. Compared to women whose cervical cancer ... Pap smear increased their cure rate from 66 percent to ...
... news for the 27,000 plus people around the world who ... living kidney donors for 10 years found that they were ... general population. Led by Dr. Amit Garg, ... London Health Sciences Centre, the results provide important safety reassurances ...
Cached Medicine News:Health News:Standardized outcome measures proposed for asthma clinical research 2Health News:College Women's Condom Use Falls During Freshman Year 2Health News:How does cannabis affect working memory? 2Health News:How does cannabis affect working memory? 3Health News:Regular Pap Smear Boosts Cervical Cancer Survival: Study 2Health News:Regular Pap Smear Boosts Cervical Cancer Survival: Study 3Health News:First study of its kind finds no increased risk of heart disease for kidney donors 2
... is ideal as a primary chemistry-immuno ... and laboratories or as a dedicated ... and consolidate chemistry-immuno testing with Olympus ... chemistry, specific proteins, esoteric chemistries and ...
This kit has been designed for the quantitative,determination of total immunoreactive intact PTH (Total,Intact PTH) in blood samples. The Total Intact PTH,level is the sum of PTH (1-84) and N-t...
... PoleStar N20, exclusively distributed by Medtronic, ... Combining intra-operative imaging with surgical ... PoleStar N20 is one of the ... , , Exceptional image quality from ...
Microwell IRMA for the detection of Intact PTH...
Medicine Products: